CHRISTY ALEXANDER: Open Payments
NPI 1508854035 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 31 payments from 12 companies in 2025. Trend: 2023 $76 · 2024 $229 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $302 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Astellas Pharma US Inc | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: UBRELVY, QULIPTA, AIRSUPRA, VRAYLAR, Veozah, GARDASIL 9, TRINTELLIX, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
